🔎 Trials Near Me

Nyumbani › Neoplasm za Myeloproliferative

Majaribio ya kliniki ya Neoplasm za Myeloproliferative yanayovutia washiriki nchini Marekani

Masomo 50 ya Neoplasm za Myeloproliferative yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07469891

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06131801

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06661915

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05320198

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT04282187

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT03471260

Cord Blood Transplant in Adults With Blood Cancers

InaajiriHatua 2
Umri 21 hadi 65 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT05884333

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT06291987

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04493164

Project: Every Child for Younger Patients With Cancer

InaajiriUtafiti wa uchunguzi
Hadi umri 25 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT02402244

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Inaajiri
Umri 19 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04898790

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT07008118

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT07249840

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT07441694

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

InaajiriHatua 2
6 Months – 65 Years · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT06013423

Evaluation of the Pathobiology of CALR-mutated MPN Cells

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT06480591

Allo HSCT Using RIC and PTCy for Hematological Diseases

InaajiriHatua 2
Hadi umri 75 · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT05805605

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.